Researcher Marketers

 IMARC Group, a leading market research company, has recently releases report titled “ Blood Plasma Derivatives Market Report by Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and Others), Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand's Disease, and Others), End User (Hospitals, Clinics, and Others), and Region 2024-2032 ”, Offers a comprehensive analysis of the industry, which comprises insights on the market. How Big Is the Blood Plasma Derivatives Market? The global blood plasma derivatives market size reached US$ 45.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 74.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032. Factors Affecting the Growth of the Blood Plasma Derivatives Industry:       Rising Prevalence of Chronic Diseases and Immune Deficiency Disorders: The increasing incidence of chronic diseases and immune defici...

 According to the latest report by IMARC Group, titled " Blood Plasma Derivatives Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027 ", the global blood plasma derivatives market reached a value of US$ 40.5 Billion in 2021 . Looking forward, IMARC Group expects the market to reach a value of US$ 59.8 Billion by 2027 , exhibiting a CAGR of 6.40% during 2022-2027 . Blood plasma derivatives are concentrated proteins prepared from plasma that is separated through physico-chemical or other fractionation processes and traced based on the lot or batch number. These derivatives are rich in proteins, salts, hormones, protease inhibitors, minerals, and vitamins. Consequently, they help control body temperature and coagulation of blood, maintain osmotic pressure, enhance respiration and excretion, and regulate acid-base balance. Owing to these properties, blood plasma derivatives are widely used to kill viruses that cause hepatitis B, bleeding disor...